ANAHEIM, Calif. – PolyOne Corporation (NYSE: POL), a premier global provider of specialized polymer materials, services and solutions, will feature its specialty solutions for medical manikin and training model applications at Medical Design and Manufacturing (MD&M) West 2014 (booth 3213) this week.
PolyOne’s collection of specialty solutions help customers gain a competitive advantage by incorporating innovative, high performance technology. These latest solutions build on a long history of working closely with unique realistic skin materials to leading medical manikin and training model manufacturers.
“We’ve seen growth in demand for medical manikins and training models, putting, manufacturers under constant pressure to differentiate and find ways to quickly introduce innovative new products,” said James Petrie, marketing director, PolyOne Color and Additives. “MD&M West represents an excellent opportunity for us to help our customers explore ways to differentiate from the competition and grow their business.”
The PolyOne portfolio of specialty solutions includes:
Geon™ Sensation Injection-Moldable Vinyl Plastisol is currently available in North America; all other solutions within the portfolio are available globally.
About PolyOne
PolyOne Corporation, with 2013 revenues of $3.8 billion, is a premier provider of specialized polymer materials, services and solutions. The company is dedicated to serving customers in diverse industries around the globe, by creating value through collaboration, innovation and an unwavering commitment to excellence. Guided by its Core Values, Sustainability Promise and No Surprises PledgeSM, PolyOne is committed to its customers, employees, communities and shareholders through ethical, sustainable and fiscally responsible principles. For more information, visit www.polyone.com.
# # #
To access PolyOne’s news library online, please go to www.polyone.com/news.
Media contacts
Michelle Maniscalco
Marketing Communications Manager, North America
PolyOne Corporation
+1 440-930-1988
michelle.maniscalco@avient.com
Avient Announces Registration Details for December 4th Investor Day... More
Avient Announces Third Quarter 2024 Results... More
Avient Announces Fourteenth Consecutive Annual Dividend Increase... More